Complex global trials.
Delivered.
I lead cross-functional, multi-region clinical programs — from first-in-human to global Phase III — on time, on budget, and at the quality your program deserves.
Three ways sponsors work with me.
Engagements typically combine all three — anchored in one mandate, extending into the others as the program demands.
- 01
Clinical Operations Leadership
Interim or fractional Clinical Operations Director for Phase I–III programs. Leading global execution teams and the operational strategy of trials that span continents.
- 02
Due Diligence & External Collaboration
Scientific and operational diligence for licensing, M&A and partnerships. Assessment of external assets and start-ups, with board- and investor-ready output.
- 03
Public Speaking & Expert Representation
Keynotes at investigator meetings, congresses and corporate events; representing clinical programs to executives, regulators and KOLs.
I'm not only an operational project manager. I build bridges — between science and operations, between local teams and global structures, between cultures and regions. That bridge is usually what decides whether a complex program succeeds.
End-to-end perspective
Preclinical research through global Phase III, in start-ups and in large pharma.
Truly global complexity
Programs running simultaneously across North America, Europe, LATAM and APAC, under regulatory and budget pressure.
Called in when it matters
When projects stall, complexity grows or alignment breaks — I restore structure, transparency and decision-making.
Let's talk about your program.
Whether you're scoping a new global trial, recovering a delayed program, or evaluating an external asset — start with a conversation.